Porter J M, Taylor L M
J Vasc Surg. 1985 Mar;2(2):239-49. doi: 10.1067/mva.1985.avs0020239.
The optimal role of thrombolytic therapy in clinical practice has not been defined precisely. A review of available information indicates that such therapy may be useful in a small number of carefully selected patients with deep vein thrombosis and/or pulmonary emboli. The superiority of thrombolytic therapy over conventional surgery for arterial thrombi has not been convincingly demonstrated. Available evidence suggests such therapy should be reserved for those conditions in which surgery may be expected to have a poor outcome or be associated with a high incidence of complications. Preliminary information suggests thrombolytic therapy may be of benefit in selected patients with acute myocardial infarction.
溶栓治疗在临床实践中的最佳作用尚未得到精确界定。对现有信息的回顾表明，这种治疗可能对少数经过精心挑选的深静脉血栓形成和/或肺栓塞患者有用。溶栓治疗相对于动脉血栓传统手术的优越性尚未得到令人信服的证明。现有证据表明，这种治疗应保留用于那些预计手术效果不佳或并发症发生率高的情况。初步信息表明，溶栓治疗可能对某些急性心肌梗死患者有益。
